Literature DB >> 14600243

Tetra-amino-acid tandem repeats are involved in HsdS complementation in type IC restriction-modification systems.

Monika Adamczyk-Popławska1, Aneta Kondrzycka1, Katarzyna Urbanek1, Andrzej Piekarowicz1.   

Abstract

All known type I restriction and modification (R-M) systems of Escherichia coli and Salmonella enterica belong to one of four discrete families: type IA, IB, IC or ID. The classification of type I systems from a wide range of other genera is mainly based on complementation and molecular evidence derived from the comparison of the amino acid similarity of the corresponding subunits. This affiliation was seldom based on the strictest requirement for membership of a family, which depends on relatedness as demonstrated by complementation tests. This paper presents data indicating that the type I NgoAV R-M system from Neisseria gonorrhoeae, despite the very high identity of HsdM and HsdR subunits with members of the type IC family, does not show complementation with E. coli type IC R-M systems. Sequence analysis of the HsdS subunit of several different potential type IC R-M systems shows that the presence of different tetra-amino-acid sequence repeats, e.g. TAEL, LEAT, SEAL, TSEL, is characteristic for type IC R-M systems encoded by distantly related bacteria. The other regions of the HsdS subunits potentially responsible for subunit interaction are also different between a group of distantly related bacteria, but show high similarity within these bacteria. Complementation between the NgoAV R-M system and members of the EcoR124 R-M family can be restored by changing the tetra-amino-acid repeat within the HsdS subunit. The authors propose that the type IC family of R-M systems could consist of several complementation subgroups whose specificity would depend on differences in the conserved regions of the HsdS polypeptide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600243     DOI: 10.1099/mic.0.26497-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  Deletion of one nucleotide within the homonucleotide tract present in the hsdS gene alters the DNA sequence specificity of type I restriction-modification system NgoAV.

Authors:  Monika Adamczyk-Poplawska; Michal Lower; Andrzej Piekarowicz
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

2.  A model for the evolution of prokaryotic DNA restriction-modification systems based upon the structural malleability of Type I restriction-modification enzymes.

Authors:  Edward K M Bower; Laurie P Cooper; Gareth A Roberts; John H White; Yvette Luyten; Richard D Morgan; David T F Dryden
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

3.  Adaptative potential of the Lactococcus lactis IL594 strain encoded in its 7 plasmids.

Authors:  Roman K Górecki; Anna Koryszewska-Bagińska; Marcin Gołębiewski; Joanna Żylińska; Marcin Grynberg; Jacek K Bardowski
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

4.  DNA target recognition domains in the Type I restriction and modification systems of Staphylococcus aureus.

Authors:  Laurie P Cooper; Gareth A Roberts; John H White; Yvette A Luyten; Edward K M Bower; Richard D Morgan; Richard J Roberts; Jodi A Lindsay; David T F Dryden
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

5.  Genetic variation regulates the activation and specificity of Restriction-Modification systems in Neisseria gonorrhoeae.

Authors:  Leonor Sánchez-Busó; Daniel Golparian; Julian Parkhill; Magnus Unemo; Simon R Harris
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

6.  Removal of a frameshift between the hsdM and hsdS genes of the EcoKI Type IA DNA restriction and modification system produces a new type of system and links the different families of Type I systems.

Authors:  Gareth A Roberts; Kai Chen; Laurie P Cooper; John H White; Garry W Blakely; David T F Dryden
Journal:  Nucleic Acids Res       Date:  2012-09-23       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.